Metraipolis › archive › dc_33a599faadcd

Clinical efficacy, safety, and success factors of botulinum toxin type A in the treatment of acute acquired comitant esotropia — Europe PMC PMID:41678132

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41678132
DOI: 10.1007/s10384-[numero omesso]-6
License (as archived): solo-consultazione
Archived: 2026-11-05T21:30:13.563Z
SHA-256 of the archived text: 848323b03640770cb6bc99d358b7b1341545c5649bfa82ab232e0836e3792788
Stable URL of this page: https://metraipolis.com/documento/dc_33a599faadcd

How to cite

Clinical efficacy, safety, and success factors of botulinum toxin type A in the treatment of acute acquired comitant esotropia — Europe PMC PMID:41678132 — Europe PMC (en), https://europepmc.org/article/MED/41678132 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_33a599faadcd (Metraipolis archive dc_33a599faadcd, sha256 848323b03640770cb6bc99d358b7b1341545c5649bfa82ab232e0836e3792788)

BibTeX

@misc{dc33a599faadcd,
  title = {Clinical efficacy, safety, and success factors of botulinum toxin type A in the treatment of acute acquired comitant esotropia — Europe PMC PMID:41678132},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41678132},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_33a599faadcd; sha256 848323b03640770cb6bc99d358b7b1341545c5649bfa82ab232e0836e3792788},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41678132. Agents can read the archived copy with the MCP tool read_document.